Clinical and pharmacological risk assessment for thrombohaemorrhagic complications after total lower limb arthroplasty

Background. Anticoagulant and haemostatic drugs are used to prevent thrombosis and bleeding after arthroplasty. Combined therapy with these divergent agents, especially in comorbid patients, is not regulated in relevant clinical guidelines and may lead to a reduced effi cacy.

Objectives. Assessment of the effect of time interval (TI) in variant combined settings of haemostatic and anticoagulant drugs and concomitant pathology on the development of thrombohaemorrhagic complications after hip or knee arthroplasty.

Мethods. In a retrospective study, we analysed patients’ somatic status, haemostatic and anticoagulant drug regimes and their combined impact on the development of thrombohaemorrhagic complications in early postoperative period.

Results. We analysed 253 case histories with total replacement of main lower limb joints. Two cohorts were defi ned with respect to TI between haemostatic and anticoagulant drug applications. TI was 17 h or less (n = 145; 57.31%) in cohort 1 and 18–24 h (n = 108; 42.68%) — in cohort 2. A total of 29 drug combinations were tested. Thrombohaemorrhagic complications were observed in 27 (10.67%) patients, with 22 (81.48%) in cohort 1. Thromboses in regimes with tranexamic acid developed in cohort 1 (p = 0.038) at a 2.2-folds higher rate than in cohort 2 (p < 0.05). Thrombosis development was infl uenced by grade 2 obesity (relative risk = 8.75, p = 0.037), type 2 diabetes (relative risk = 21, p = 0.00001), myocardial infarction (relative risk = 16.875, p = 0.00002), venous pathology (relative risk = 8.1, p = 0.045) and the patient’s age over 75 (relative risk = 6.8, p = 0.029). Age over 75 years increased the risk of bleeding by a factor of 12 (relative risk = 12, p = 0.015).

Conclusion. After main joint arthroplasty, differential measures to prevent thrombohaemorrhagic complications include a minimal 18-h TI between haemostatic and anticoagulant agent applications, especially in tranexamic acid regimes, and the consideration of concomitant risk factors, such as grade 2 obesity, type 2 diabetes, myocardial infarction in history, venous pathology and age over 75 years.

1. Kashevarova N.G., Alekseeva L.I. Risk factors of the knee osteoarthritis progression. Rheumatology Science and Practice. 2014; 52(5): 553–561 (In Russ., English abstract). DOI: 10.14412/1995-4484-2014-553-561

2. Keurentjes J.C., Van Tol F.R., Fiocco M., Schoones J.W., Nelissen R.G. Minimal clinically important differences in health-related quality of life after total hip or knee replacement: A systematic review. Bone Joint Res. 2012; 1(5): 71–77. DOI: 10.1302/2046-3758.15.2000065

3. Singh J.A. Epidemiology of knee and hip arthroplasty: a systematic review. Open Orthop. J. 2011; 5: 80–85. DOI: 10.2174/1874325001105010080

4. Leitner L., Türk S., Heidinger M., Stöckl B., Posch F., Maurer-Ertl W., et al. Trends and Economic Impact of Hip and Knee Arthroplasty in Central Europe: Findings from the Austrian National Database. Sci. Rep. 2018; 8(1): 4707. DOI: 10.1038/s41598-018-23266-w

5. Singh J.A., Yu S., Chen L., Cleveland J.D. Rates of total joint replacement in the united states: future projections to 2020-2040 using the National Inpatient Sample. J. Rheumatol. 2019; 46(9): 1134–1140. DOI: 10.3899/jrheum.170990

6. Tikhilov R.M., Shubnyakov I.I., Kovalenko A.N., Cherniy A.Z., Muravyeva Y.V., Goncharov M.Y. Data of hip arthroplasty registry of Vreden Institute for the period 2007–2012 years. Traumatology and Orthopedics of Russia. 2013; (3): 167–190 (In Russ., English abstract). DOI: 10.21823/2311-2905-2013-3-167-190

7. Kornilov N.N., Kulyaba T.A., Fil A.S., Muravyeva Y.V. Data of knee arthroplasty register of Vreden Russian Research Institute of Traumatology and Orthopedics for period 2011–2013. Traumatology and Orthopedics of Russia. 2015; (1): 136–151 (In Russ., English abstract). DOI: 10.21823/2311-2905-2015-0-1-136-151

8. Es’Kin N.A., Andreeva T.M. State of Specialized Trauma and Orthopaedic Care in the Russian Federation. Vestnik Travmatologii i Ortopedii imeni N.N. Priorova. 2017; (1): 5–11 (In Russ., English abstract). DOI: 10.32414/0869-8678-2017-1-5-11

9. Bozhkova S.A., Kasimova A.R., Nakopia V.B., Kornilov N.N. Do we know all about prevention of venous thromboembolism after major orthopedic surgery? Traumatology and Orthopedics of Russia. 2018; 24(1): 129–143 (In Russ., English abstract). DOI: 10.21823/2311-2905-2018-24-1-129-143

10. Almegren M.O., Alhedaithy A.A., Alomri A.S., Albawardy N.F., Mesmar R.S., Al Qahtani M.A. Venous thromboembolism after total knee and hip arthroplasty. A retrospective study. Saudi medical journal. 2018; 39(11): 1096–1101. DOI: 10.15537/smj.2018.11.23545

11. Rybnikov A.V., Byalik E.I., Reshetnyak T.M., Makarov S.A., Khramov A.E. The prevention of venous thromboembolism and the risk of postoperative complications in patients with rheumatoid arthritis and osteoarthritis after total hip arthroplasty. Rheumatology Science and Practice. 2018; 56(6): 797–804 (In Russ., English abstract). DOI: 10.14412/1995-4484-2018-797-804

12. Nakopiya V.B., Kornilov N.N., Bozhkova S.A., Kazemirskiy A.V., Goncharov M.Y. Hidden blood loss after total knee arthroplasty with complex tromboprophylaxis. Modern Problems of Science and Education. 2017; (6): 97 (In Russ., English abstract). DOI: 10.17513/spno.27272

13. European Society of Cardiology. European Society of Anaesthesilogy. 2014 ESC/ESA guidelines on non-cardiac surgery: cardiovascular assessment and management. Russian Journal of Cardiology. 2015; (8): 7–66 (In Russ., English abstract). DOI: 13. 10.15829/1560-4071-2015-8-7-66

14. Krasnova N.M., Sychev D.A., Aleksandrova T.N., Vengerovskii A.I. Risk of postoperative venous thromboembolic complication development in elderly patients. Bulletin of Siberian Medicine. 2018; 17(1): 85–93 (In Russ., English abstract). DOI: 10.20538/1682-0363-2018-1-85-93

15. Yousef A.I., Akhtyamov I.F. Arthroplasty features in overweight patients (review). Traumatology and Orthopedics of Russia. 2017; 23(2): 115–123 (In Russ., English abstract). DOI: 10.21823/2311-2905-2017-23-2-115-123

16. Cherkasov M.A., Tikhilov R.M., Shubnyakov I.I., Kovalenko A.N., Mugutdinov Z.A. Patient satisfaction following total hip replacement: predictors of success. Traumatology and Orthopedics of Russia. 2018; 24(3): 45–54 (In Russ., English abstract). DOI: 10.21823/2311-2905-2018-24-3-45-54